Pantoprazol Davur (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Davur, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑intestinal conditions such as GERD in adult patients. GNH USA supplies Pantoprazol Davur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Davur is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. It is indicated for several gastrointestinal disorders: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: accelerates mucosal healing and reduces risk of complications. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.

Pantoprazol Davur may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of stomach upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea, fever, abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat, seizures. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice, dark urine, fatigue. - Acute interstitial nephritis: reduced urine output, flank pain, swelling.

Before initiating therapy with Pantoprazol Davur, consider the following safety measures: - Assess renal function: adjust dosing in severe renal impairment. - Review concomitant medications: evaluate for potential drug‑drug interactions. - Monitor magnesium levels: especially during prolonged therapy. - Evaluate bone health: consider calcium and vitamin D supplementation for long‑term users. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Davur can affect the pharmacokinetics of several co‑administered drugs. Interaction management is essential for patient safety.

Major Interactions (Avoid): - Ketoconazole oral suspension: markedly reduced antifungal absorption. - Atazanavir: substantially decreased antiviral efficacy. - Clopidogrel: diminished antiplatelet activity, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values; monitor coagulation. - Methotrexate: increased systemic exposure; check renal function and drug levels. - Digoxin: slight increase in serum concentrations; observe for toxicity signs.